Latest

Hodgkin’s Lymphoma Market Poised for Strong Growth Through 2034, Driven by Innovative Therapies and Clinical Advancements | DelveInsight

3 February 2026
DelveInsight’s “Hodgkin’s Lymphoma Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Hodgkin’s Lymphoma, historical and forecasted epidemiology and the FSGS market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and

Antisense Oligonucleotide Therapeutics Treatment Pipeline Shows Strong Momentum as 70+ Pharma Companies in the Race | DelveInsight

2 February 2026
DelveInsight’s, “Antisense Oligonucleotide Therapeutics Pipeline Insights 2025” report provides comprehensive insights about 70+ companies and 90+ pipeline drugs in the Antisense Oligonucleotide Therapeutics pipeline landscape. It covers the Antisense Oligonucleotide Therapeutics pipeline drug profiles, including clinical and nonclinical stage products. It also covers
1 … 43 44 45 46 47 … 53